P2Y 2 receptor expression is regulated by C/EBPβ during inflammation in intestinal epithelial cells

FEBS Journal

Volumn 279, Issue 16, 2012, Pages 2957-2965

  Degagné, Émilie ^a   Turgeon, Naomie ^a   Moore Gagné, Julie ^a   Asselin, Claude ^a   Gendron, Fernand Pierre ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

C EBP; colitis; gene regulation; intestinal epithelial cells; P2Y 2 receptor

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; PURINERGIC P2Y2 RECEPTOR; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; COLITIS; CONTROLLED STUDY; EMBRYO; ENTERITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INFLAMMATION; INTESTINE EPITHELIUM CELL; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CACO-2 CELLS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; COLITIS; DEXTRAN SULFATE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RATS; RECEPTORS, PURINERGIC P2Y2;

MUS;

EID: 84864399470     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08676.x     Document Type: Article

References (36)

1. Abraham C, &, Cho JH, (2009) Inflammatory bowel disease. N Engl J Med 361, 2066-2078.
2. Laukoetter MG, Nava P, &, Nusrat A, (2008) Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol 14, 401-407. (Pubitemid 351320848)
3. Sturm A, &, Dignass AU, (2008) Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol 14, 348-353. (Pubitemid 351320844)
4. Kirsner JB, Sartor RB, &, Sandborn WJ, (2004) Kirsner's Inflammatory Bowel Diseases. Elsevier Inc., Philadelphia, PA.
5. Yoshida H, &, Granger DN, (2009) Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm Bowel Dis 15, 1245-1255.
6. Danese S, (2008) Nonimmune cells in inflammatory bowel disease: from victim to villain. Trends Immunol 29, 555-564.
7. Grbic DM, Degagne E, Langlois C, Dupuis AA, &, Gendron FP, (2008) Intestinal inflammation increases the expression of the P2Y6 receptor on epithelial cells and the release of CXC chemokine ligand 8 by UDP. J Immunol 180, 2659-2668.
8. Ardizzone S, Cassinotti A, Duca P, Mazzali C, Penati C, Manes G, Marmo R, Massari A, Molteni P, Maconi G, et al. (2011) Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol 9, 483-489.
9. 6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP-1-dependent manner in epithelial cells. Inflamm Bowel Dis doi:.
10. 2 receptor. Eur J Immunol 39, 2895-2905.
11. Di Virgilio F, Boeynaems JM, &, Robson SC, (2009) Extracellular nucleotides as negative modulators of immunity. Curr Opin Pharmacol 9, 507-513.
12. 2 released by intestinal epithelial cells. J Immunol 183, 4521-4529.
13. Di Virgilio F, &, Robson SC, (2009) Identification of novel immunosuppressive pathways paves the way for drug discovery. Curr Opin Pharmacol 9, 445-446.
14. 2 receptor promotes intestinal epithelial cell migration through a Go protein and integrin αv pathway allowing microtubule stabilization and mucosal re-epithelization in experimental colitis. J Cell Physiol doi:.
15. Abbracchio MP, &, Burnstock G, (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors?. Pharmacol Ther 64, 445-475. (Pubitemid 24381231)
16. von Kugelgen I, &, Wetter A, (2000) Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 362, 310-323.
17. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, et al. (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58, 281-341. (Pubitemid 44394905)
18. Ferrero ME, (2012) Purinoceptors in inflammation: potential as anti-inflammatory therapeutic targets. Front Biosci 17, 2172-2186.
19. Mei L, Du W, Gao W, &, Mei QB, (2010) Purinergic signaling: a novel mechanism in immune surveillance. Acta Pharmacol Sin 31, 1149-1153.
20. Erb L, Liao Z, Seye CI, &, Weisman GA, (2006) P2 receptors: intracellular signaling. Pflugers Arch 452, 552-562. (Pubitemid 44015090)
21. Bilbao PS, Santillan G, &, Boland R, (2010) ATP stimulates the proliferation of MCF-7 cells through the PI3K/Akt signaling pathway. Arch Biochem Biophys 499, 40-48.
22. Bagchi S, Liao Z, Gonzalez FA, Chorna NE, Seye CI, Weisman GA, &, Erb L, (2005) The P2Y2 nucleotide receptor interacts with αv integrins to activate Go and induce cell migration. J Biol Chem 280, 39050-39057. (Pubitemid 41713855)
23. o-mediated signal transduction. J Cell Biol 153, 491-501. (Pubitemid 34280137)
24. Ramji DP, &, Foka P, (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365, 561-575. (Pubitemid 34864439)
25. Boudreau F, Blais S, &, Asselin C, (1996) Regulation of CCAAT/enhancer binding protein isoforms by serum and glucocorticoids in the rat intestinal epithelial crypt cell line IEC-6. Exp Cell Res 222, 1-9. (Pubitemid 26046574)
26. Gheorghiu I, Deschenes C, Blais M, Boudreau F, Rivard N, &, Asselin C, (2001) Role of specific CCAAT/enhancer-binding protein isoforms in intestinal epithelial cells. J Biol Chem 276, 44331-44337.
27. Poli V, (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273, 29279-29282. (Pubitemid 28509923)
28. Andoh A, Shioya M, Nishida A, Bamba S, Tsujikawa T, Kim-Mitsuyama S, &, Fujiyama Y, (2009) Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease. J Immunol 183, 687-695.
29. Araki Y, Sugihara H, &, Hattori T, (2006) In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis. Oncol Rep 16, 1357-1362.
30. Cha-Molstad H, Agrawal A, Zhang D, Samols D, &, Kushner I, (2000) The Rel family member P50 mediates cytokine-induced C-reactive protein expression by a novel mechanism. J Immunol 165, 4592-4597.
31. Mukerjee R, Sawaya BE, Khalili K, &, Amini S, (2007) Association of p65 and C/EBPβ with HIV-1 LTR modulates transcription of the viral promoter. J Cell Biochem 100, 1210-1216. (Pubitemid 46480403)
32. Stein B, Cogswell PC, &, Baldwin AS Jr, (1993) Functional and physical associations between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol Cell Biol 13, 3964-3974. (Pubitemid 23187624)
33. Koria P, &, Andreadis ST, (2007) KGF promotes integrin α5 expression through CCAAT/enhancer-binding protein-β. Am J Physiol Cell Physiol 293, C1020-C1031. (Pubitemid 47437393)
34. Damm S, Koefinger P, Stefan M, Wels C, Mehes G, Richtig E, Kerl H, Otte M, &, Schaider H, (2010) HGF-promoted motility in primary human melanocytes depends on CD44v6 regulated via NF-κB, Egr-1, and C/EBP-β. J Invest Dermatol 130, 1893-1903.
35. Sterneck E, Tessarollo L, &, Johnson PF, (1997) An essential role for C/EBPβ in female reproduction. Genes Dev 11, 2153-2162. (Pubitemid 27387967)
36. Perreault N, &, Beaulieu JF, (1998) Primary cultures of fully differentiated and pure human intestinal epithelial cells. Exp Cell Res 245, 34-42. (Pubitemid 28551053)